+49 711 500 989 80
deen

Researchers unlock immune cell contributions that could lead to new therapies for endometrial cancer



Researchers unlock immune cell contributions that could lead to new therapies for endometrial cancer

Endometrial cancer is the most common cancer of the female reproductive system. Patients who have active immune responses against cancer cells tend to have better outcomes, but much of what is known focuses on only one type of immune cell called T cells. Researchers now provide insight on the role of B cell immunity in endometrial cancer.

Materials provided by H. Lee Moffitt Cancer Center & Research Institute. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

16th January 2022

MAPK4 emerges as a novel therapeutic target for triple-negative breast cancer

Read more
16th January 2022

Nuclei-free cells prove utility in delivering therapeutics to diseased tissues

Read more
15th January 2022

Blood test helps predict who may benefit from lung cancer screening

Read more